TRex Bio Stock (NASDAQ:TRXB)
Previous Close
$14.80
52W Range
$13.21 - $15.50
50D Avg
$14.01
200D Avg
$14.01
Market Cap
$122.80M
Avg Vol (3M)
$321.54K
Beta
-
Div Yield
-
TRXB Company Profile
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.